Palliative treatment of Erdheim-Chester disease with radiotherapy: A Rare Cancer Network study

Robert C. Miller, Salvador Villà, Serra Kamer, David Pasquier, Philip Poortmans, Oliver Micke, Timothy G. Call

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

A retrospective study of the use of palliative external beam radiotherapy (EBRT) in nine patients with Erdheim-Chester disease was conducted through the Rare Cancer Network. Patients received EBRT for bone pain, brain infiltration, or retro-orbital involvement. EBRT typically provided short-term palliation, with later recurrence of symptoms in most cases.

Original languageEnglish (US)
Pages (from-to)323-326
Number of pages4
JournalRadiotherapy and Oncology
Volume80
Issue number3
DOIs
StatePublished - Sep 1 2006

Keywords

  • CTCAE
  • Common Terminology Criteria for Adverse Events
  • EBRT
  • ECD
  • Erdheim-Chester disease
  • Histiocytosis
  • Non-Langerhans cell
  • Radiotherapy
  • external beam radiotherapy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Palliative treatment of Erdheim-Chester disease with radiotherapy: A Rare Cancer Network study'. Together they form a unique fingerprint.

  • Cite this

    Miller, R. C., Villà, S., Kamer, S., Pasquier, D., Poortmans, P., Micke, O., & Call, T. G. (2006). Palliative treatment of Erdheim-Chester disease with radiotherapy: A Rare Cancer Network study. Radiotherapy and Oncology, 80(3), 323-326. https://doi.org/10.1016/j.radonc.2006.07.034